Suzhou Highfine Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Cash & Equivalents	534.56	408.66	361.08	1,740	99.32	78.05
Trading Asset Securities	829.87	902.02	1,346	30.76	60	45
Cash & Short-Term Investments	1,364	1,311	1,707	1,770	159.32	123.05
Cash Growth	-19.96%	-23.23%	-3.56%	1011.12%	29.48%	20.56%
Accounts Receivable	182.38	189.26	98.34	63.56	53.42	69.11
Other Receivables	1.24	1.44	11.78	0.49	1.71	3.47
Receivables	183.62	190.7	110.12	64.05	55.12	72.58
Inventory	165.84	161.18	116.7	115	113.45	78.89
Prepaid Expenses	-	-	0.03	-	-	-
Other Current Assets	45.84	27.43	10.1	14.69	24.77	15.72
Total Current Assets	1,760	1,690	1,944	1,964	352.67	290.24
Property, Plant & Equipment	720.09	631.42	320.39	286.46	206.24	142.63
Long-Term Investments	123.24	122.6	-	-	-	-
Goodwill	57.85	57.85	-	-	-	-
Other Intangible Assets	106.71	105.43	66.33	24.02	24.59	25.17
Long-Term Deferred Tax Assets	11.52	11.99	4.39	3.66	3.95	2.37
Long-Term Deferred Charges	0.32	0.35	0.1	0.08	0.26	0.29
Other Long-Term Assets	32.95	34.76	14.14	8.71	12.34	4.4
Total Assets	2,812	2,654	2,350	2,287	600.05	465.09
Accounts Payable	265.07	77.65	27.21	24.9	36.46	25.59
Accrued Expenses	10.31	25.74	17.95	16.68	23.26	15.24
Short-Term Debt	10.01	10.01	-	-	-	-
Current Portion of Long-Term Debt	1.17	0.03	-	-	-	-
Current Portion of Leases	-	1.38	1.68	0.83	1.04	1.03
Current Income Taxes Payable	7.21	4.42	4.59	3.28	13.94	5.84
Current Unearned Revenue	1.9	0.78	1.38	0.61	0.6	2.34
Other Current Liabilities	29.6	118.86	18.35	19.53	34.04	34.8
Total Current Liabilities	325.27	238.87	71.16	65.84	109.33	84.84
Long-Term Debt	76.18	39.47	-	-	-	-
Long-Term Leases	0.45	0.44	1.6	0.72	0.39	1.17
Long-Term Unearned Revenue	8.87	9.22	7.65	8.45	7.94	6.52
Long-Term Deferred Tax Liabilities	7.1	7.24	0.94	0.07	0.12	-
Total Liabilities	417.87	295.24	81.35	75.08	117.77	92.53
Common Stock	108	108	108	108	81	81
Additional Paid-In Capital	1,692	1,690	1,686	1,683	54.79	54.79
Retained Earnings	616.83	583.39	511.55	417.69	345.72	236.6
Treasury Stock	-33.42	-33.42	-42	-	-	-
Comprehensive Income & Other	5.71	4.95	4.44	2.99	0.77	0.18
Total Common Equity	2,389	2,353	2,268	2,212	482.28	372.57
Minority Interest	5.64	6.33	-	-	-	-
Shareholders' Equity	2,395	2,359	2,268	2,212	482.28	372.57
Total Liabilities & Equity	2,812	2,654	2,350	2,287	600.05	465.09
Total Debt	87.8	51.33	3.28	1.56	1.43	2.2
Net Cash (Debt)	1,277	1,259	1,704	1,769	157.9	120.85
Net Cash Growth	-24.99%	-26.10%	-3.66%	1020.18%	30.65%	19.58%
Net Cash Per Share	11.84	11.75	15.75	19.12	1.95	1.50
Filing Date Shares Outstanding	107.18	107.18	106.97	108	81	81
Total Common Shares Outstanding	107.18	107.18	106.97	108	81	81
Working Capital	1,434	1,451	1,873	1,898	243.34	205.4
Book Value Per Share	22.29	21.95	21.20	20.48	5.95	4.60
Tangible Book Value	2,224	2,190	2,202	2,188	457.68	347.4
Tangible Book Value Per Share	20.75	20.43	20.58	20.26	5.65	4.29
Buildings	-	266.28	183.65	171.81	74.32	64.69
Machinery	-	320.25	163.79	76.02	65.92	61.8
Construction In Progress	-	217.39	21.65	72.45	87.92	28.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.